Cytodyn Inc (CYDY)

[C-20]

I think that’s why there is a need to use 4 doses instead of only 2. I’m not sure why it would be a problem switching from 2 to 4 if the results for the patient is better with 4. It’s a very simple adjustment that should be allowed now and in the future. This type of scrutiny over a situation like this is unnecessary that’s what the trials should be for to figure out what makes the drug achieve the highest efficacy it can and still be safe . I’m sure the FDA would balk at us changing our dosage as they clearly would like to see our drug get shelved . Don’t worry we will eventually be used in every hospital around the world that is the end game. Yesterday I was very impatient about the revenue happening right away but we must remain calm and not easily be deterred from our investment. GLTA